[1]
MILGROM H, STOLL HL Jr, CRISSEY JT. DYSKERATOSIS CONGENITA. A CASE WITH NEW FEATURES. Archives of dermatology. 1964 Mar:89():345-9
[PubMed PMID: 14096348]
Level 3 (low-level) evidence
[2]
Savage SA, Alter BP. Dyskeratosis congenita. Hematology/oncology clinics of North America. 2009 Apr:23(2):215-31. doi: 10.1016/j.hoc.2009.01.003. Epub
[PubMed PMID: 19327580]
[3]
Kirwan M, Dokal I. Dyskeratosis congenita, stem cells and telomeres. Biochimica et biophysica acta. 2009 Apr:1792(4):371-9. doi: 10.1016/j.bbadis.2009.01.010. Epub 2009 Feb 7
[PubMed PMID: 19419704]
[4]
Calado RT, Young NS. Telomere diseases. The New England journal of medicine. 2009 Dec 10:361(24):2353-65. doi: 10.1056/NEJMra0903373. Epub
[PubMed PMID: 20007561]
[5]
Ballew BJ, Savage SA. Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders. Expert review of hematology. 2013 Jun:6(3):327-37. doi: 10.1586/ehm.13.23. Epub
[PubMed PMID: 23782086]
[6]
Deng Z, Glousker G, Molczan A, Fox AJ, Lamm N, Dheekollu J, Weizman OE, Schertzer M, Wang Z, Vladimirova O, Schug J, Aker M, Londoño-Vallejo A, Kaestner KH, Lieberman PM, Tzfati Y. Inherited mutations in the helicase RTEL1 cause telomere dysfunction and Hoyeraal-Hreidarsson syndrome. Proceedings of the National Academy of Sciences of the United States of America. 2013 Sep 3:110(36):E3408-16. doi: 10.1073/pnas.1300600110. Epub 2013 Aug 19
[PubMed PMID: 23959892]
Level 3 (low-level) evidence
[7]
Knight SW, Heiss NS, Vulliamy TJ, Greschner S, Stavrides G, Pai GS, Lestringant G, Varma N, Mason PJ, Dokal I, Poustka A. X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene. American journal of human genetics. 1999 Jul:65(1):50-8
[PubMed PMID: 10364516]
[8]
Kirwan M, Dokal I. Dyskeratosis congenita: a genetic disorder of many faces. Clinical genetics. 2008 Feb:73(2):103-12
[PubMed PMID: 18005359]
[9]
Alter BP, Giri N, Savage SA, Rosenberg PS. Cancer in dyskeratosis congenita. Blood. 2009 Jun 25:113(26):6549-57. doi: 10.1182/blood-2008-12-192880. Epub 2009 Mar 12
[PubMed PMID: 19282459]
[10]
Bongiorno M, Rivard S, Hammer D, Kentosh J. Malignant transformation of oral leukoplakia in a patient with dyskeratosis congenita. Oral surgery, oral medicine, oral pathology and oral radiology. 2017 Oct:124(4):e239-e242. doi: 10.1016/j.oooo.2017.08.001. Epub 2017 Aug 12
[PubMed PMID: 28923296]
[11]
Monoi A, Sugawa M, Kato M, Seki M, Yoshida K, Shiraishi Y, Sakaguchi H, Ogawa S, Takita J. Atypical dyskeratosis congenita diagnosed using whole-exome sequencing. Pediatrics international : official journal of the Japan Pediatric Society. 2017 Aug:59(8):933-935. doi: 10.1111/ped.13314. Epub 2017 Jun 23
[PubMed PMID: 28643950]
[12]
Güngör Ş, Erdemir AV, Göncü EK, Gürel MS, Özekinci S. A case of dyskeratosis congenita with dermoscopic and reflectance confocal microscopic features. Journal of the American Academy of Dermatology. 2015 Jul:73(1):e11-3. doi: 10.1016/j.jaad.2015.02.1141. Epub
[PubMed PMID: 26089061]
Level 3 (low-level) evidence
[13]
Kutbay NO, Yurekli BS, Erdemir Z, Karaca E, Unal I, Yaman B, Ozkinay F, Saygili F. A case of dyskeratosis congenita associated with hypothyroidism and hypogonadism. Hormones (Athens, Greece). 2016 Apr:15(2):297-299. doi: 10.14310/horm.2002.1655. Epub
[PubMed PMID: 27376432]
Level 3 (low-level) evidence
[14]
Powell JB, Dokal I, Carr R, Taibjee S, Cave B, Moss C. X-linked dyskeratosis congenita presenting in adulthood with photodamaged skin and epiphora. Clinical and experimental dermatology. 2014 Apr:39(3):310-4. doi: 10.1111/ced.12272. Epub
[PubMed PMID: 24635067]
[15]
Revesz T, Fletcher S, al-Gazali LI, DeBuse P. Bilateral retinopathy, aplastic anaemia, and central nervous system abnormalities: a new syndrome? Journal of medical genetics. 1992 Sep:29(9):673-5
[PubMed PMID: 1404302]
[16]
Piard J, Holder-Espinasse M, Aral B, Gigot N, Rio M, Tardieu M, Puzenat E, Goldenberg A, Toutain A, Franques J, MacDermot K, Bessis D, Boute O, Callier P, Gueneau L, Huet F, Vabres P, Catteau B, Faivre L, Thauvin-Robinet C. Systematic search for neutropenia should be part of the first screening in patients with poikiloderma. European journal of medical genetics. 2012 Jan:55(1):8-11. doi: 10.1016/j.ejmg.2011.07.004. Epub 2011 Aug 18
[PubMed PMID: 21872685]
Level 1 (high-level) evidence
[17]
Gadalla SM, Sales-Bonfim C, Carreras J, Alter BP, Antin JH, Ayas M, Bodhi P, Davis J, Davies SM, Deconinck E, Deeg HJ, Duerst RE, Fasth A, Ghavamzadeh A, Giri N, Goldman FD, Kolb EA, Krance R, Kurtzberg J, Leung WH, Srivastava A, Or R, Richman CM, Rosenberg PS, Toledo Codina JS, Shenoy S, Socié G, Tolar J, Williams KM, Eapen M, Savage SA. Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2013 Aug:19(8):1238-43. doi: 10.1016/j.bbmt.2013.05.021. Epub 2013 Jun 8
[PubMed PMID: 23751955]
[18]
Islam A, Rafiq S, Kirwan M, Walne A, Cavenagh J, Vulliamy T, Dokal I. Haematological recovery in dyskeratosis congenita patients treated with danazol. British journal of haematology. 2013 Sep:162(6):854-6. doi: 10.1111/bjh.12432. Epub 2013 Jun 19
[PubMed PMID: 23782100]
[19]
Aalfs CM, van den Berg H, Barth PG, Hennekam RC. The Hoyeraal-Hreidarsson syndrome: the fourth case of a separate entity with prenatal growth retardation, progressive pancytopenia and cerebellar hypoplasia. European journal of pediatrics. 1995 Apr:154(4):304-8
[PubMed PMID: 7607282]
Level 3 (low-level) evidence